Phibro Animal Health Co. (NASDAQ:PAHC) Declares Quarterly Dividend of $0.12

by · The Cerbat Gem

Phibro Animal Health Co. (NASDAQ:PAHC – Get Free Report) declared a quarterly dividend on Tuesday, November 5th, Zacks reports. Investors of record on Wednesday, November 27th will be paid a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend is Wednesday, November 27th.

Phibro Animal Health has a dividend payout ratio of 32.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Phibro Animal Health to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.1%.

Phibro Animal Health Trading Up 0.3 %

NASDAQ:PAHC traded up $0.08 during trading hours on Thursday, hitting $23.17. The company had a trading volume of 8,889 shares, compared to its average volume of 154,040. The company has a debt-to-equity ratio of 1.79, a current ratio of 2.94 and a quick ratio of 1.64. Phibro Animal Health has a 52 week low of $9.40 and a 52 week high of $25.11. The company has a market capitalization of $938.39 million, a PE ratio of 388.90, a price-to-earnings-growth ratio of 0.55 and a beta of 0.51. The stock has a 50-day moving average price of $22.28 and a 200 day moving average price of $19.24.

Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. The firm had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. On average, equities research analysts predict that Phibro Animal Health will post 1.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Bank of America raised their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $15.00.

Read Our Latest Research Report on PAHC

Insider Activity at Phibro Animal Health

In related news, Director E Thomas Corcoran acquired 5,000 shares of the stock in a transaction on Wednesday, September 4th. The stock was acquired at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now owns 25,000 shares of the company’s stock, valued at $500,500. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 50.07% of the stock is owned by corporate insiders.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Stories